| 000 | 01819 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515125253.0 | ||
| 264 | 0 | _c20081007 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/j.vaccine.2008.05.080 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrymula, Roman | |
| 245 | 0 | 0 |
_aSafety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines. _h[electronic resource] |
| 260 |
_bVaccine _cAug 2008 |
||
| 300 |
_a4563-70 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 |
_aBacterial Proteins _ximmunology |
| 650 | 0 | 4 |
_aCarrier Proteins _ximmunology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHaemophilus Vaccines _xadverse effects |
| 650 | 0 | 4 |
_aHepatitis A Vaccines _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 |
_aImmunoglobulin D _ximmunology |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLipoproteins _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPneumococcal Vaccines _xadverse effects |
| 650 | 0 | 4 |
_aVaccines, Conjugate _ximmunology |
| 700 | 1 | _aChlibek, Roman | |
| 700 | 1 | _aSplino, Miroslav | |
| 700 | 1 | _aKaliskova, Eva | |
| 700 | 1 | _aKohl, Igor | |
| 700 | 1 | _aLommel, Patricia | |
| 700 | 1 | _aSchuerman, Lode | |
| 773 | 0 |
_tVaccine _gvol. 26 _gno. 35 _gp. 4563-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2008.05.080 _zAvailable from publisher's website |
| 999 |
_c18085049 _d18085049 |
||